Viewing Study NCT06439693


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-01-04 @ 11:44 PM
Study NCT ID: NCT06439693
Status: RECRUITING
Last Update Posted: 2025-06-26
First Post: 2024-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module